HMGB1-IN-3
HMGB1-IN-3 (compound E) is a glycyrrhizic acid derivative with strong inhibitory activity against HMGB1 (high mobility group protein 1) and can be used in the study of intracerebral hemorrhage.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 5195-71-1
- 分子式: C31H46O4
- 分子量:482.69
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| 518A2 | IC50 |
>30 μM
Compound: 11
|
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| 518A2 | IC50 |
>30 μmol
Compound: 11
|
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
Cytotoxicity against human 518A2 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| 518A2 | EC50 |
>30 μM
Compound: 11
|
Cytotoxicity against human 518A2 cells assessed as cell survival after 96 hrs by SRB assay
Cytotoxicity against human 518A2 cells assessed as cell survival after 96 hrs by SRB assay
|
[PMID: 26177446] |
| 8505C | IC50 |
>30 μM
Compound: 11
|
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| 8505C | IC50 |
>30 μmol
Compound: 11
|
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
Cytotoxicity against human 8505C cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| 8505C | EC50 |
20.5 μM
Compound: 11
|
Cytotoxicity against human 8505C cells assessed as cell survival after 96 hrs by SRB assay
Cytotoxicity against human 8505C cells assessed as cell survival after 96 hrs by SRB assay
|
[PMID: 26177446] |
| A253 cell line | IC50 |
>30 μmol
Compound: 11
|
Cytotoxicity against human A253 cells after 96 hrs by SRB assay
Cytotoxicity against human A253 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| A2780 | IC50 |
>30 μM
Compound: 11
|
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| A2780 | IC50 |
>30 μmol
Compound: 11
|
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
Cytotoxicity against human A2780 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| A549 | IC50 |
>30 μM
Compound: 11
|
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| A549 | IC50 |
>30 μmol
Compound: 11
|
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
Cytotoxicity against human A549 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| A549 | EC50 |
26.1 μM
Compound: 11
|
Cytotoxicity against human A549 cells assessed as cell survival after 96 hrs by SRB assay
Cytotoxicity against human A549 cells assessed as cell survival after 96 hrs by SRB assay
|
[PMID: 26177446] |
| DLD-1 | IC50 |
>30 μM
Compound: 11
|
Cytotoxicity against human DLD1 cells after 96 hrs by SRB assay
Cytotoxicity against human DLD1 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| DLD-1 | IC50 |
>30 μmol
Compound: 11
|
Cytotoxicity against human DLD1 cells after 96 hrs by SRB assay
Cytotoxicity against human DLD1 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| HT-29 | EC50 |
26.7 μM
Compound: 11
|
Cytotoxicity against human HT-29 cells assessed as cell survival after 96 hrs by SRB assay
Cytotoxicity against human HT-29 cells assessed as cell survival after 96 hrs by SRB assay
|
[PMID: 26177446] |
| MCF7 | IC50 |
>30 μM
Compound: 11
|
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| MCF7 | IC50 |
>30 μmol
Compound: 11
|
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
Cytotoxicity against human MCF7 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| MCF7 | EC50 |
16.7 μM
Compound: 11
|
Cytotoxicity against human MCF7 cells assessed as cell survival after 96 hrs by SRB assay
Cytotoxicity against human MCF7 cells assessed as cell survival after 96 hrs by SRB assay
|
[PMID: 26177446] |
| NTUB1 | IC50 |
56.5 μM
Compound: 3
|
Cytotoxicity against human NTUB1 cells after 72 hrs by MTT assay
Cytotoxicity against human NTUB1 cells after 72 hrs by MTT assay
|
[PMID: 21696969] |
| SW-1736 | IC50 |
29.09 μM
Compound: 11
|
Cytotoxicity against human SW1736 cells after 96 hrs by SRB assay
Cytotoxicity against human SW1736 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
| SW-1736 | IC50 |
29.09 μmol
Compound: 11
|
Cytotoxicity against human SW1736 cells after 96 hrs by SRB assay
Cytotoxicity against human SW1736 cells after 96 hrs by SRB assay
|
[PMID: 21959232] |
化学情報
-
CAS 番号 5195-71-1
-
分子量 482.69
-
分子式 C31H46O4
-
SMILES
C[C@]1(C(OC)=O)CC[C@]([C@@]2([H])C1)(C)CC[C@@](C2=C3)(C)[C@]4(C)CC[C@@]5([H])C(C)(C)C(CC[C@]5(C)[C@@]4([H])C3=O)=O
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Machida, et al. "A Glycyrrhizin Derivative with a More Potent Inhibitory Activity against High-Mobility Group Box 1 Efficiently Discovered by Chemical Synthesis Inspired by the Bioconversion Products of an Endophytic Fungus Isolated from Licorice." Journal of Medicinal Chemistry (2024). [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)